⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Clinical Risk Markers (ApoB, Lp(a), hs-CRP)
Current understanding
The boring blood panel with the best outcome evidence in the entire vault.
Evidence log
- 2026-10-21 — Relationship Between Social Isolation, Loneliness, and Systemic Inflammation: A Scoping Review of Biological Signatures and Clinical Outcomes.: cross-connection with epigenetic-clocks: [human-observational] The scoping review places accelerated epigenetic aging alongside elevated CRP, fibrinogen, and IL-6 as biological correlates of social disconnection; these associations do not establish that clocks add predictive value beyond inflammatory markers. (novelty: 3)
- 2026-10-27 — Stage-dependent associations of Cardiovascular-Kidney-Metabolic Syndrome with Cognitive Decline, Depression, and Neuroimaging Signatures in multi-regional older adults.: [human-observational] Multi-cohort observational analysis of 28,242 older adults associated advanced cardiovascular-kidney-metabolic (CKM) stages with faster cognitive decline and neuroimaging evidence of cerebrovascular damage; estimated attribution of roughly one-quarter of cognitive-impairment risk to modifiable factors does not establish preventability, incremental prediction beyond standard risk markers, or validation of ApoB, Lp(a), or hs-CRP individually. [human-observational] (novelty: 3)
- 2026-10-14 — Association of eGFR Discrepancy With Subsequent Frailty in Middle-Aged and Older Adults.: [human-observational] A longitudinal cohort study of middle-aged and older adults associated higher eGFR discrepancy (cystatin C–based minus creatinine-based eGFR) with a lower subsequent frailty index and lower odds of frailty, with grip-strength analyses suggesting a contribution from muscle-related differences; this does not establish incremental predictive utility over existing risk measures or that changing the discrepancy prevents frailty. [human-observational] (novelty: 3)
- 2026-10-23 — Relative handgrip strength and cardiometabolic multimorbidity among chinese middle-aged and older adults: mediation by metabolic and inflammatory pathways.: cross-connection with grip-strength-gait-speed: [human-observational] Statistical mediation by lipid dysmetabolism and insulin resistance links relative grip strength to metabolic risk-marker assessment, without establishing causal mediation or validation of specific markers such as ApoB, Lp(a), or hs-CRP. (novelty: 3)
- 2026-10-24 — The associations of triglyceride-cholesterol-body weight index and relative handgrip strength with new-onset frailty: evidence from two prospective cohort studies.: [human-observational] Two prospective cohorts (CHARLS and ELSA) linked higher triglyceride-cholesterol-body weight index and lower relative handgrip strength independently and jointly to incident frailty in middle-aged and older adults; these associations do not establish incremental predictive value over standard clinical markers or that changing either measure prevents frailty. [human-observational] (novelty: 3)
- 2026-10-12 — When Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Change Definition? A Lifespan Perspective on Menopause and Metabolic Health.: [expert-opinion] Lifespan review proposes that polyendocrine metabolic ovarian syndrome (PMOS) shifts phenotype rather than resolves at menopause, framing persistent metabolic dysregulation as relevant to postmenopausal cardiometabolic risk; it provides no new primary validation of ApoB, Lp(a), hs-CRP, or aging clocks and does not establish accelerated biological aging. [expert-opinion] (novelty: 3)
- 2026-10-01 — TyG-ABSI and TyG-WWI as insulin-resistance body shape markers of mortality in middle-aged and older adults within the cardiovascular-kidney-metabolic framework: A multi-cohort observational study with external survival-model validation.: [human-observational] Multi-cohort observational analysis of NHANES, ELSA, CHARLS, and HRS, with external survival-model validation, found TyG-ABSI and TyG-WWI insulin-resistance/body-shape composites consistently associated with all-cause mortality in middle-aged and older adults but added little discrimination beyond standard clinical risk factors; this does not establish that lowering these indices reduces mortality or reverses aging. [human-observational] (novelty: 3)
- 2026-10-07 — Chronic inflammation and multiple dimensions of aging among women in the Philippines.: 7-year longitudinal study of Filipino women (Cebu Longitudinal Health and Nutrition Survey) found baseline plasma hs-CRP predicted declines in physical and cognitive function and incident diabetes and hypertension — extends hs-CRP’s inflammaging prognostic signal into a lower-middle-income, low-obesity, higher-infectious-burden setting underrepresented in prior clinical risk-marker evidence. [human-observational] (novelty: 3)
- 2026-07-28 — First-harmonic attenuation of radial pulse waves as a sensitive marker for vascular aging.: Cross-sectional study (n=919) proposes first-harmonic attenuation of the radial pulse (imaginary component Y) as a sensitive non-invasive vascular-aging marker claimed to outperform conventional PWV — a candidate hemodynamic readout parallel to the ApoB/Lp(a)/hs-CRP panel, with no head-to-head benchmarking against clinical bloods or outcomes. [human-observational] (novelty: 3)
- 2026-08-24 — Explaining Variance in Pulse Wave Velocity in Youth: The Youth Vascular Consortium.: Youth Vascular Consortium analysis (n=6763) showed SBP and heart rate were top cfPWV predictors in ages 5–40 but the full traditional risk-factor set explained <40% of variance, with lipids only modestly relevant in young adults — bounds how much of early vascular aging the standard clinical risk panel accounts for. [human-observational] (novelty: 3)
- 2026-07-12 — Blood Biochemistry Age Clock - An interpretable estimate of biological age and predictor of all-cause-mortality derived from routinely ordered blood biomarkers.: UKB/NHANES validation of BBAC: an 11-marker clock built from routinely ordered blood biochemistry (the standard risk-panel layer) predicts all-cause mortality and eight chronic-disease incidence endpoints comparably to PhenoAge, with an optimized form beating PhenoAge on AIC — supports repackaging routine clinical labs into an interpretable phenotypic-age score, no head-to-head against ApoB/Lp(a)/hs-CRP specifically. [human-observational] (novelty: 3)
- 2026-08-14 — Identifying biomarkers of accelerated ageing in cancer patients from routine clinical data.: Geriatric oncology observational analysis: a PhenoAge-style score built from routine clinical blood tests outperformed chronological age for one-year mortality and frailty, and appeared higher after systemic anti-cancer treatment — reinforces that repackaging standard risk-panel analytes into a phenotypic-age composite adds prognostic signal in oncology, with no benchmarking against ApoB/Lp(a)/hs-CRP specifically. [human-observational] (novelty: 3)
- 2026-10-05 — Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.: Large Korean <50 cohort: a composite built from routine clinical labs (PhenoAge) stratified early-onset colorectal adenocarcinoma risk independently of chronological age — supports repackaging the standard clinical-lab layer into a phenotypic-age score for cancer risk stratification in younger adults, observational. [human-observational] (novelty: 3)
- 2026-10-06 — A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.: Same CKMAI NHANES analysis: an ML aging index built from clinical labs, nutrition, lifestyle, and social determinants outperformed the single-domain cardiometabolic index (CMI) and two general biological-age clocks for mortality and high-risk CKM status — supports repackaging routine clinical risk analytes into composite ML scores for CKM-syndrome stratification, observational and no intervention test. [human-observational] (novelty: 3)
- 2026-08-18 — Circulating biomarkers and polygenic scores for cardiovascular risk prediction in healthy older adults: differential and complementary contributions.: ASPREE-derived prospective analysis (n=10,433 healthy ≥70 CVD-free adults) showed hsCRP, NT-proBNP, and hsTnI added more discrimination for incident MACE on top of traditional risk factors than CAD/stroke polygenic scores, while PGSs contributed relatively more to case reclassification — a direct quantification of how the standard risk-marker panel and genomic risk layer sit as complementary rather than redundant inputs in older adults. [human-observational] (novelty: 3)
- 2026-07-07 — AI-driven advances in vascular aging research: From mechanisms to precision medicine.: Review positions AI-derived multi-omic and imaging-based vascular aging biomarkers as a precision-medicine layer intended to complement conventional cardiovascular risk markers for early detection and individualized stratification — synthesis argument, no head-to-head benchmarking against the ApoB/Lp(a)/hs-CRP panel. [expert-opinion] (novelty: 3)
- 2026-07-14 — A compendium of circulating biomarkers of senescence in humans: Insights on mechanistic impact across health domains and modulation by therapeutic interventions.: Compendium argues circulating SASP markers (GDF15, Activin A) index senescence burden with cross-domain outcome associations and respond to senotherapeutic interventions — raises the question of whether these should sit alongside ApoB/Lp(a)/hs-CRP in a clinical risk layer, but no head-to-head benchmarking against the standard panel. [expert-opinion] (novelty: 3)
- 2026-08-15 — Functional vulnerability beyond blood pressure: Intrinsic capacity impairment and cardiovascular risk stratification in three prospective aging cohorts.: Three-cohort pooled analysis (CHARLS/ELSA/HRS) showed WHO intrinsic capacity impairment added only modest discrimination for incident CVD on top of hypertension, with the two carrying independent and joint risk — a direct though incremental head-to-head between a functional-aging composite and a core clinical risk marker. [human-observational] (novelty: 3)
- 2026-09-04 — Healthy ageing trajectories and incident cardiovascular disease in adults aged 50 years and older: a multi-cohort study.: cross-connection with intrinsic-capacity: Healthy-ageing trajectories across SHARE/ELSA/CHARLS predict incident CVD independently of lifestyle score, raising the question of whether functional-trajectory metrics add incremental risk discrimination over conventional ApoB/Lp(a)/hs-CRP panels. (novelty: 3)
- 2026-08-12 — Clonal hematopoiesis of undetermined potential as an emerging determinant of inflammageing, and age-related diseases: Potential role as biomarker and target.: cross-connection with clonal-hematopoiesis: Review positions CHIP alongside established inflammatory and cardiovascular risk markers (e.g., hs-CRP) as a candidate inflammaging biomarker, raising the question of whether CHIP screening should layer onto existing clinical risk panels. (novelty: 3)
- 2026-03-08 — Edentulousness and Frailty: A Study of Directionality and Pathways.: ELSA cross-lagged mediation analysis found hs-CRP partially mediated the edentulousness→frailty path (alongside loneliness), extending hs-CRP’s role as an inflammaging intermediary into the oral-health→functional-decline pathway; mediation effect was small and observational. [human-observational] (novelty: 3)
- 2025-11-18 — Glycemic status-dependent proteomic signatures of biological aging for health risk prediction.: cross-connection with aging-omic-biomarkers: Glycemic-stratified ProAS adds mortality and disease prediction beyond conventional clinical risk factors, linking proteomic clock construction to the clinical risk-marker baseline it must outperform to earn use. (novelty: 3)
- 2026-05-19 — High cardiorespiratory fitness is associated with younger brain age: the role of systemic inflammation.: cross-connection with brain-mri-biological-age: Systemic inflammation (hs-CRP-type markers) partly mediates the fitness–brain-age association, connecting a standard clinical inflammation marker to a neuroimaging clock. (novelty: 3)
- 2026-09-14 — #407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and promising new therapies | Michael Davidson, M.D.: Peter Attia Drive #407 with lipidologist Michael Davidson argues that earlier-life LDL/ApoB lowering compounds cardiovascular risk reduction and may extend to Alzheimer’s prevention, with APOE4 carriers as a priority subgroup and emerging LDL-lowering therapies in the pipeline; podcast expert synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-09-25 — Longitudinal proteomic organ-specific aging in heart failure.: cross-connection with omics-aging-signatures: Organ-specific proteomic age gaps predicted heart-failure outcomes independently of established cardiac clinical markers (NT-proBNP, troponin T), a first direct head-to-head between an omic aging readout and standard clinical risk biomarkers in HF. (novelty: 4)
- 2026-09-12 — Association Between Iron Availability and Accelerated Biological Aging in Non-Anemic Women of Reproductive Age: A Nationally Representative Cross-Sectional Study.: NHANES cross-sectional analysis flagged sTfR index (a routine iron-status lab) as tracking PhenoAge acceleration in non-anemic reproductive-age women — suggests a subclinical iron-availability signal sitting in the standard clinical-lab layer that is not captured by the ApoB/Lp(a)/hs-CRP panel; associational, no outcome data. [human-observational] (novelty: 3)
- 2026-09-24 — The GrimAge clock corresponds to brain ageing and social determinants of health in people with HIV.: In virally suppressed PWH, GrimAge acceleration tracked cardiovascular risk alongside neighborhood deprivation and cognitive deficits — supports GrimAge as partially indexing the same cardiometabolic risk terrain that ApoB/Lp(a)/hs-CRP panels cover in this population, without head-to-head benchmarking against those bloods. [human-observational] (novelty: 3)
- 2026-09-14 — Cardiovascular frailty - an emerging frailty phenotype.: Narrative review on ‘cardiovascular frailty’ argues BP dynamics, vascular-ageing markers, and oxi-inflammaging (overlapping hs-CRP territory) should be read together with frailty status as a bidirectionally-linked phenotype rather than as separate risk layers; conceptual synthesis only, no new data. [expert-opinion] (novelty: 3)
- 2026-09-21 — Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.: Cross-sectional study (n=457 dementia-free late midlife/older adults) linked higher peripheral inflammatory markers (cytokine composite, hs-CRP, GFAP) to altered white-matter microstructure on multi-shell NODDI and conventional dMRI, independent of plasma AD biomarkers — extends hs-CRP’s outcome relevance into a brain-imaging inflammaging readout, though a single cross-sectional association is not an outcome. [human-observational] (novelty: 3)
- 2026-09-20 — Association of B-Type Natriuretic Peptide With Intrinsic Capacity Trajectories Among Chinese Older Adults.: Prospective Chinese older-adult cohort linked elevated and persistent BNP to lower baseline WHO intrinsic capacity and 4-year IC decline even in CVD-free participants — positions BNP (a standard cardiac risk marker) as also tracking a functional-aging trajectory beyond its cardiac-outcome use. [human-observational] (novelty: 3)
- 2026-09-23 — Multidimensional Aging Trajectories Preceding Cardiovascular Events.: ASPREE nested case-control found functional aging measures (frailty, intrinsic capacity, physical HRQOL) diverged from CVD-free controls up to a decade before adjudicated CVD events — a pre-event signal operating in a measurement layer orthogonal to the ApoB/Lp(a)/hs-CRP panel, though this analysis did not benchmark head-to-head against clinical bloods. [human-observational] (novelty: 3)
- 2026-09-15 — Biological Age Acceleration Predicts Functional Decline and Surgical Risk in Knee Arthroplasty.: Retrospective TKA cohort: composite biological-age acceleration derived from standard clinical blood biomarkers predicted perioperative complications and postoperative gait speed better than chronological age — supports the idea that repackaging routine risk-panel analytes into a phenotypic-age score adds surgical prognostic signal beyond their individual use. [human-observational] (novelty: 3)
- 2026-09-12 — Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality.: cross-connection with omics-aging-signatures: PIS is built from and benchmarked against conventional inflammatory markers (including hs-CRP), positioning a composite proteomic inflammaging score as a candidate successor to single clinical inflammation readouts for mortality prediction. (novelty: 3)
- 2026-09-09 — Apolipoprotein(a)-rich electronegative HDL accelerates vascular aging and atherosclerosis by inducing endothelial senescence.: Case-control + mechanistic paper on Apo(a)-rich electronegative HDL (H5) reports independent association with carotid IMT/plaque beyond conventional lipids and a p53–p21 endothelial-senescence mechanism, arguing HDL quality/subfractionation adds a vascular-aging layer the ApoB/Lp(a)/hs-CRP panel misses; no outcome trial and no standardized assay yet. [human-observational] (novelty: 3)
- 2026-09-10 — A vascular-muscle-adiposity phenotype and incident stroke risk in middle-aged and older adults: a multi-cohort study.: Multi-cohort observational study showed a simple three-item phenotype (MAP + grip strength + waist-to-height ratio) predicted incident stroke (pooled HR 1.30 per adverse step; 1.94 for 3 vs 0), suggesting cheap composite functional-vascular-anthropometric measures capture stroke risk in a layer parallel to the ApoB/Lp(a)/hs-CRP cardiometabolic panel; no head-to-head against clinical bloods. [human-observational] (novelty: 3)
- 2026-09-12 — Impact of caloric restriction on biological aging: insights from a composite biomarker index in older adults.: Pooled analysis of seven caloric-restriction RCTs in older adults reported improvement on a composite biomarker index of biological aging (built partly from clinical risk-panel analytes), with only ~50% of the effect mediated by weight loss — suggesting CR shifts the standard clinical risk layer via mechanisms beyond adiposity, though improvement on a composite index is not itself an outcome. [human-rct] (novelty: 3)
- 2026-09-08 — 100-Year Human Aging Study: Announcement of the 100-Year Human Aging Study, which plans to benchmark clinical risk markers alongside omic and functional readouts against hard mortality/disease/disability endpoints — study design only, no results. [expert-opinion] (novelty: 4)
- 2026-08-13 — Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried: Huberman Lab Essentials with Sara Gottfried frames perimenopausal cardiometabolic risk as a driver of accelerated ApoB/lipid/inflammation deterioration in women and argues the standard risk panel should be read against decade-specific hormone context rather than sex-neutral cutoffs; expert-media commentary, no new primary data. [expert-opinion] (novelty: 3)
- 2026-06-22 — Age-related metabolomic signatures and stroke susceptibility in a population-based cohort.: cross-connection with omics-aging-signatures: Triglyceride-enriched lipoprotein NMR signatures linked to stroke subtypes bridge metabolomic aging signatures with the traditional cardiometabolic risk-marker layer, suggesting the metabolomic panel adds incremental subtype resolution beyond standard lipid/inflammation markers. (novelty: 3)
- 2026-08-04 — Association of neurofilament light chain, CXCL9, IL-6, and TNFRSF11B with intrinsic capacity in community-dwelling older adults.: Cross-sectional older-adult study added NfL and a small inflammatory protein set (CXCL9, IL-6, TNFRSF11B) as correlates of WHO intrinsic capacity, orthogonal to the ApoB/Lp(a)/hs-CRP cardiometabolic panel and pointing at neuro-inflammatory axes not captured by standard clinical bloods. [human-observational] (novelty: 3)
- 2026-06-29 — Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.: Conceptual review positions ApoB/Lp(a)/hs-CRP-type panels as downstream readouts within a hierarchical hallmark network and calls for their integration with upstream primary-driver biomarkers (DNA damage load, telomere metrics, sex-hormone trajectory, especially peri-menopausal) rather than being used in isolation — no new empirical data. [expert-opinion] (novelty: 3)
- 2026-07-01 — Liver- and Immune-Enriched Molecular Signatures Associated With Mortality in Older Adults.: Observational older-adult cohort found a 20-protein plasma score predicted all-cause mortality better than conventional clinical risk factors, with external validation — a head-to-head signal that curated proteomic signatures can exceed the standard clinical risk panel in this population, though not yet a deployable assay. [human-observational] (novelty: 3)
- 2026-06-26 — Association of the Frailty-to-Estimated Cardiorespiratory Fitness Ratio with Prevalent Stroke in Middle-Aged and Older Adults: A Cross-Sectional NHANES Study.: cross-connection with frailty-to-crf-ratio: FCR is positioned as an integrative load-to-reserve composite alongside single-analyte cardiovascular risk markers; both target stroke/CVD outcomes but from orthogonal measurement layers (functional reserve vs circulating biology). (novelty: 3)
- 2026-08-01 — An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.: Preclinical + human cohort report (Nature/Cell-tier style paper) proposes circulating ANGPTL8 as a candidate mortality/biological-age predictor via an adipose AKT2-mTOR-S6K senescence axis; mouse Angptl8 knockout extended lifespan, but human data are observational associations, not a validated clinical assay. [human-observational] (novelty: 4)
Open questions
Related
Contributing findings
Effect of subnormal estimated glomerular filtration rate on mortality varies by obesity metrics: a two-dimensional exposure-response analysis.
11-nov-2026
novelty 2
per-area 2
strengthens
Evidence generation for diabetes prevention and treatment through the integration of clinical medicine, nutritional epidemiology, and behavioral science.
10-nov-2026
novelty 2
per-area 2
strengthens
Cytokines and hematological indices as potential markers of low cardiorespiratory fitness and sarcopenia in hemodialysis patients.
09-nov-2026
novelty 2
per-area 2
strengthens
EXPRESS: Associations of the triglyceride/HDL-cholesterol ratio and triglyceride-glucose index with malnutrition risk and other geriatric parameters in older adults: a retrospective cross-sectional study.
06-nov-2026
novelty 2
per-area 2
weakens
Prognostic value of the red blood cell distribution width-to-albumin ratio in alcohol-related sarcopenia.
03-nov-2026
novelty 2
per-area 2
strengthens
Association between plasma docosahexaenoic acid levels and the incidence of frailty: A prospective analysis of the UK Biobank.
28-oct-2026
novelty 3
per-area 2
mentions
Beyond reproduction: the emerging role of FSH in postmenopausal aging.
28-oct-2026
novelty 3
per-area 2
strengthens
Stage-dependent associations of Cardiovascular-Kidney-Metabolic Syndrome with Cognitive Decline, Depression, and Neuroimaging Signatures in multi-regional older adults.
27-oct-2026
novelty 3
per-area 3
strengthens
The associations of triglyceride-cholesterol-body weight index and relative handgrip strength with new-onset frailty: evidence from two prospective cohort studies.
24-oct-2026
novelty 3
per-area 3
strengthens
Leptin Neutralization Attenuates Inflammaging in Endothelial and Immune Cell Models.
23-oct-2026
novelty 3
per-area 2
strengthens
Cardiovascular health and longevity: where are we?
22-oct-2026
novelty 2
per-area 2
mentions
Associations of longitudinal patterns of central obesity and chronic low-grade inflammation with incident frailty in middle-aged and older adults.
21-oct-2026
novelty 3
per-area 2
strengthens
Prevalence and Associated Factors of Dual Physical and Cognitive Impairment Among Adults Aged 50 Years and Older with Cardiometabolic Conditions: A Cross-Sectional Study.
15-oct-2026
novelty 2
per-area 2
mentions
Thyroid function and frailty in hospitalized older adults: the role of FT3 and FT3/FT4 ratio.
14-oct-2026
novelty 2
per-area 2
strengthens
Association of eGFR Discrepancy With Subsequent Frailty in Middle-Aged and Older Adults.
14-oct-2026
novelty 3
per-area 3
strengthens
Associations Between Early Vascular Aging and Quality of Life in the Adult Population: Pooled Data From 2 Epidemiological Studies.
13-oct-2026
novelty 2
per-area 2
strengthens
When Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Change Definition? A Lifespan Perspective on Menopause and Metabolic Health.
12-oct-2026
novelty 3
per-area 3
strengthens
Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data.
11-oct-2026
novelty 2
per-area 2
mentions
Adropin signaling pathways in metabolic and non-metabolic disorders.
10-oct-2026
novelty 2
per-area 2
mentions
Triglyceride-related metabolic indices and low relative muscle mass: a cross-sectional analysis of SMILE and NHANES.
07-oct-2026
novelty 2
per-area 2
strengthens
Chronic inflammation and multiple dimensions of aging among women in the Philippines.
07-oct-2026
novelty 3
per-area 3
strengthens
A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.
06-oct-2026
novelty 3
per-area 3
strengthens
The Biomarkers That Predict Mortality Risk
05-oct-2026
novelty 2
per-area 2
strengthens
Accelerated Biological Aging and Risk of Early-Onset Colorectal Cancer: Findings from a Large Prospective East Asian Cohort.
05-oct-2026
novelty 3
per-area 3
strengthens
Impact of lipid accumulation product on cardiometabolic multimorbidity and the mediating effect of leukocytes: evidence from a prospective cohort study among middle-aged and elderly chinese adults.
05-oct-2026
novelty 2
per-area 3
strengthens
The Dortmund Vital Study: Impact of Biological and Lifestyle Factors on Cognitive Performace and Work Ability
02-oct-2026
novelty 2
per-area 1
mentions
TyG-ABSI and TyG-WWI as insulin-resistance body shape markers of mortality in middle-aged and older adults within the cardiovascular-kidney-metabolic framework: A multi-cohort observational study with external survival-model validation.
01-oct-2026
novelty 3
per-area 3
strengthens
Cardiometabolic dysfunction and age at natural menopause: a prospective study.
01-oct-2026
novelty 3
per-area 2
strengthens
Systemic inflammation, gut microbiome composition, and cognitive performance among older Ugandans with Alzheimer's disease and related dementias: A cross-sectional study.
01-oct-2026
novelty 2
per-area 2
weakens
Associations of Life's Essential 10 with Mortality and Healthspan Free of Cardiovascular Disease and Cancer: Findings in Two Nationwide Cohorts.
01-oct-2026
novelty 3
per-area 2
strengthens
Relationship Between Albumin/Creatine Ratio, B12, Folate, and Frailty Index
30-sep-2026
novelty 2
per-area 2
mentions
Personalized primary cardiovascular prevention: the convergences of risk scores, coronary calcium scoring and lipoprotein (a).
29-sep-2026
novelty 2
per-area 2
strengthens
Exploration of cytokines relating to masked obesity in Japanese women.
28-sep-2026
novelty 2
per-area 1
mentions
Comparison between exercise and hot water immersion on skin microvascular responses in older adults with overweight and obesity.
28-sep-2026
novelty 3
per-area 1
mentions
Association between the triglyceride-glucose-body mass index and the risk of early vascular aging in young and middle-aged Chinese adults: a cross-sectional study.
25-sep-2026
novelty 2
per-area 2
strengthens
Proposing a Novel Set of Proxy Measures of Aging Rate
24-sep-2026
novelty 2
per-area 1
mentions
The GrimAge clock corresponds to brain ageing and social determinants of health in people with HIV.
24-sep-2026
novelty 3
per-area 3
strengthens
Role of Inflammatory Markers in the Progression of Arterial Stiffness and Mortality: A Multicenter Longitudinal Cohort Study.
24-sep-2026
novelty 2
per-area 2
strengthens
Photoplethysmographic Signal Analysis for Vascular Ageing Assessment.
23-sep-2026
novelty 3
per-area 2
mentions
Multidimensional Aging Trajectories Preceding Cardiovascular Events.
23-sep-2026
novelty 3
per-area 3
strengthens
Immune Aging and Advanced Therapy Outcomes in Older Adults With IBD
22-sep-2026
novelty 2
per-area 2
mentions
PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study
22-sep-2026
novelty 2
per-area 1
mentions
Could defining arterial resilience identify protective factors for vascular ageing?
22-sep-2026
novelty 2
per-area 2
mentions
Phenotypic age metrics for risk stratification of chronic disease burden and all-cause mortality in adults.
22-sep-2026
novelty 2
per-area 1
mentions
Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.
21-sep-2026
novelty 3
per-area 3
strengthens
Association of B-Type Natriuretic Peptide With Intrinsic Capacity Trajectories Among Chinese Older Adults.
20-sep-2026
novelty 3
per-area 3
strengthens
Editor's Note on Association of B-Type Natriuretic Peptide With Intrinsic Capacity Trajectories Among Chinese Older Adults.
20-sep-2026
novelty 1
per-area 1
mentions
Trajectory-Oriented Brain Vulnerability Framework for Cognitive Decline in Type 2 Diabetes.
19-sep-2026
novelty 2
per-area 1
mentions
Association of smoking behaviors with GOLD biological age acceleration and potential mediation: Evidence from NHANES 1999-2023.
18-sep-2026
novelty 2
per-area 2
strengthens
A Frailty-specific Prehabilitation Program for Mild to Moderately Frail Patients Undergoing Cardiac Surgeries/Procedures
17-sep-2026
novelty 2
per-area 1
mentions